Cleared Traditional

K923511 - CK-NAC ACTIVATED KIT

K923511 is an FDA 510(k) clearance for CK-NAC ACTIVATED KIT, manufactured by Randox Laboratories, Ltd.. The device is a Class 2 Chemistry device with product code CGS cleared through the Traditional 510(k) pathway after a 92-day FDA review.

K923511 · Randox Laboratories, Ltd. · Chemistry device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1992
Decision
92d
Days
Class 2
Risk

K923511 is an FDA 510(k) clearance for the CK-NAC ACTIVATED KIT. Classified as Nad Reduction/nadh Oxidation, Cpk Or Isoenzymes (product code CGS), Class II - Special Controls.

Submitted by Randox Laboratories, Ltd. (Antrim, N. Ireland, IR). The FDA issued a Cleared decision on October 15, 1992 after a review of 92 days - within the typical 510(k) review window.

This device falls under the Chemistry FDA review panel, regulated under 21 CFR 862.1215 - the FDA in vitro diagnostics and chemistry framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Chemistry review framework, consistent with the majority of Class II 510(k) submissions.

View all Randox Laboratories, Ltd. devices

FDA 510(k) Submission Details - K923511

510(k) Number K923511 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 15, 1992
Decision Date October 15, 1992
Days to Decision 92 days
Submission Type Traditional
Review Panel Chemistry (CH)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
4d slower than avg
Panel avg: 88d · This submission: 92d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CGS Device Classification - Class 2, Special Controls

Product Code CGS Nad Reduction/nadh Oxidation, Cpk Or Isoenzymes
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1215
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Chemistry devices follow this clearance model.

Regulatory Peers - CGS Nad Reduction/nadh Oxidation, Cpk Or Isoenzymes

All 117
Devices cleared under the same product code (CGS) and FDA review panel - the closest regulatory comparables to K923511.
CREATINE KINASE (CK) REAGENT SET
K930660 · Pointe Scientific, Inc., · Mar 1993
OLYMPUS CREATINE KINASE REAGENT
K924832 · Olympus Corp. · Jan 1993
REP E-Z CK-30 ISOENZYME KIT
K925801 · Helena Laboratories · Dec 1992
CREATINE KINASE (CK) TEST ITEM #65411
K924704 · Em Diagnostic Systems, Inc. · Oct 1992
OLYMPUS CREATINE KINASE REAGENT
K922459 · Olympus Corp. · Jul 1992
CREATINE KINASE MB TEST ITEM NUMBER 5A46
K914361 · Em Diagnostic Systems, Inc. · Dec 1991